Tyra Biosciences (TYRA) Cash from Operations (2020 - 2026)
Quarterly Cash from Operations fell 27.94% to 32571000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 102255000.0 through Mar 2026, down 39.68% year-over-year, with the annual reading at 95142000.0 for FY2025, 36.36% down from the prior year.
Tyra Biosciences filings provide 7 years of Cash from Operations readings, the most recent being 32571000.0 for Q1 2026.
- Cash from Operations hit 32571000.0 in Q1 2026 for Tyra Biosciences, down from 23624000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8925000.0 in Q1 2022 and bottomed at 32571000.0 in Q1 2026.
- Average Cash from Operations over 5 years is 17524176.47, with a median of 17168000.0 recorded in 2022.
- The largest annual shift saw Cash from Operations plummeted 284.85% in 2022 before it soared 43.99% in 2023.
- Tyra Biosciences' Cash from Operations stood at 11980000.0 in 2022, then decreased by 12.95% to 13532000.0 in 2023, then tumbled by 44.77% to 19590000.0 in 2024, then dropped by 20.59% to 23624000.0 in 2025, then plummeted by 37.87% to 32571000.0 in 2026.
- Per Business Quant, the three most recent readings for TYRA's Cash from Operations are 32571000.0 (Q1 2026), 23624000.0 (Q4 2025), and 22380000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.08 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | -32.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.57 Mn |
| Mar 31, 2026 | -32.57 Mn |
| Dec 31, 2025 | -23.62 Mn |
| Dec 31, 2025 | -23.62 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Jun 30, 2025 | -23.68 Mn |
| Jun 30, 2025 | -23.68 Mn |
| Mar 31, 2025 | -25.46 Mn |
| Mar 31, 2025 | -25.46 Mn |
| Dec 31, 2024 | -19.59 Mn |
| Dec 31, 2024 | -19.59 Mn |
| Sep 30, 2024 | -17.90 Mn |
| Sep 30, 2024 | -17.90 Mn |
| Jun 30, 2024 | -10.26 Mn |
| Jun 30, 2024 | -10.26 Mn |
| Mar 31, 2024 | -22.03 Mn |
| Mar 31, 2024 | -22.03 Mn |
| Dec 31, 2023 | -13.53 Mn |
| Dec 31, 2023 | -13.53 Mn |
| Sep 30, 2023 | -17.15 Mn |
| Sep 30, 2023 | -17.15 Mn |
| Jun 30, 2023 | -9.62 Mn |
| Jun 30, 2023 | -9.62 Mn |
| Mar 31, 2023 | -9.85 Mn |
| Mar 31, 2023 | -9.85 Mn |
| Dec 31, 2022 | -11.98 Mn |
| Dec 31, 2022 | -11.98 Mn |
| Sep 30, 2022 | -12.21 Mn |
| Sep 30, 2022 | -12.21 Mn |
| Jun 30, 2022 | -17.17 Mn |
| Jun 30, 2022 | -17.17 Mn |
| Mar 31, 2022 | -8.93 Mn |
| Mar 31, 2022 | -8.93 Mn |
| Dec 31, 2021 | -9.03 Mn |
| Dec 31, 2021 | -9.03 Mn |
| Sep 30, 2021 | -5.58 Mn |
| Sep 30, 2021 | -5.58 Mn |
| Jun 30, 2021 | -4.46 Mn |
| Jun 30, 2021 | -4.46 Mn |
| Mar 31, 2021 | -4.68 Mn |
| Mar 31, 2021 | -4.68 Mn |
| Dec 31, 2020 | -2.53 Mn |
| Dec 31, 2020 | -2.53 Mn |